Related Experiment Video

Updated: Aug 21, 2026

Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation
09:13

Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation

Published on: April 6, 2017

Potassium chloride supplementation diminishes platelet reactivity in humans

Masayuki Kimura1, Xiaobin Lu, Joan Skurnick

  • 1Hypertension Research Center, Cardiovascular Research Institute, University of Medicine and Dentistry of New Jersey, Newark 07103, USA.

Hypertension (Dallas, Tex. : 1979)
|October 27, 2004
PubMed

Insights

High potassium intake reduces platelet aggregation, a key factor in blood clots. This study found that potassium supplementation decreased platelet reactivity, potentially lowering the risk of occlusive stroke.

Area of Science:

  • Cardiovascular Science
  • Hematology
  • Nutritional Science

Background:

  • Occlusive stroke prevalence is inversely linked to dietary potassium.
  • Platelet reactivity plays a critical role in thrombus formation and stroke pathogenesis.
  • Understanding modifiable dietary factors influencing platelet function is crucial for stroke prevention.

Purpose of the Study:

  • To investigate the effect of potassium supplementation on adenosine diphosphate (ADP)-evoked platelet aggregation in healthy adults.
  • To determine if increased potassium intake attenuates platelet reactivity.
  • To explore potential differences in response based on race and sex.

Main Methods:

  • A randomized controlled trial design was used with healthy men and women of black and white ethnicity.
  • Participants were supplemented with 60 mmol KCl/70 kg body weight daily for 3 days or maintained habitual intake.
  • Adenosine diphosphate (ADP)-evoked platelet aggregation was measured, and the concentration of ADP causing 50% of the maximal initial rate (EC50) was compared between groups.

Main Results:

  • Potassium supplementation significantly attenuated platelet reactivity, indicated by an increase in the EC50 of platelet aggregation (P=0.0005).
  • This effect was primarily observed in white participants, with a significant increase in EC50 (P=0.0004).
  • Black participants exhibited lower urinary potassium excretion under basal conditions and post-supplementation compared to white participants.

Conclusions:

  • Potassium supplementation effectively diminishes platelet reactivity.
  • This finding establishes a potential link between platelet biology, potassium intake, and the pathophysiology of occlusive stroke.
  • Dietary potassium may represent a modifiable factor for reducing stroke risk through its effects on platelet function.

More Related Videos

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets05:49

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets

Published on: November 29, 2024

Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells09:46

Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells

Published on: December 27, 2017

Related Concept Videos

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Roles of Electrolytes: Chloride and Bicarbonate01:29

Roles of Electrolytes: Chloride and Bicarbonate

Chloride ions contribute to the osmotic pressure gradient distinguishing the intracellular fluid (ICF) from the extracellular fluid (ECF). They counterbalance positively charged ions in the ECF and ensure its electrochemical stability. The renal system's process of chloride absorption and release generally mirrors that of sodium ions.
Conditions such as hypochloremia can arise from insufficient chloride reabsorption by the kidneys, often compounded by extended bouts of diarrhea, vomiting, or...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...
Skeletal Muscle Relaxants: Adverse Effects01:21

Skeletal Muscle Relaxants: Adverse Effects

Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Desensitization and Tachyphylaxis01:20

Desensitization and Tachyphylaxis

Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.